The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
about
sameAs
Systematic review of prevalence of aspirin induced asthma and its implications for clinical practiceAspirin-exacerbated respiratory disease: pathophysiological insights and clinical advancesEpidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burdenPrevalence of asthma with aspirin hypersensitivity in the adult population of PolandSubclinical aspirin sensitivity in subjects with nasal polyposisUrinary leukotriene E4 and 9 alpha, 11 beta-prostaglandin F concentrations in mild, moderate and severe asthma, and in healthy subjectsAspirin-sensitive asthmaParacetamol and asthmaAspirin and decreased adult-onset asthma: randomized comparisons from the physicians' health studyA functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian populationEAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivityManagement options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivityEosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.Factors driving the aspirin exacerbated respiratory disease phenotype.Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory diseaseAspirin-exacerbated asthma.Aspirin hypersensitivity and desensitization protocols: implications for cardiac patientsMajor comorbid conditions in asthma and association with asthma-related hospitalizations and emergency department admissions in adults: results from the German National Health Telephone Interview Survey (GEDA) 2010.Diagnostic value of clinical parameters in the prediction of aspirin-exacerbated respiratory disease in asthma.Clinical applications of drug desensitization in the Asia-Pacific region.Aspirin and multiple sclerosisAnesthesia and the child with asthma.The whole-genome expression analysis of peripheral blood mononuclear cells from aspirin sensitive asthmatics versus aspirin tolerant patients and healthy donors after in vitro aspirin challenge.Extrabronchial symptoms and late phase reaction enhance the diagnostic value of aspirin bronchial challenge.Guidance on the diagnosis and management of asthma among adults in resource limited settings.The time delay between drug intake and bronchospasm for nonsteroidal antiinflammatory drugs sensitive patients.Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study.Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes.Update on recent advances in the management of aspirin exacerbated respiratory disease.Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity.Aspirin-exacerbated respiratory disease: characteristics and management strategies.Mast cells in asthma--state of the art.Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis.The Role of Surgery in Management of Samter's Triad: A Systematic Review.Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease.Respiratory hypersensitivity reactions to NSAIDs in Europe: the global allergy and asthma network (GA2 LEN) survey.Cyclooxygenase-2 gene polymorphisms in an Australian population: association of the -1195G > A promoter polymorphism with mild asthma.Multiple drug intolerance including etoricoxib.
P2860
Q24600284-CB9D0ECB-F951-4DC5-9BE1-C7A44857BF9EQ26750424-4DBD50C0-A835-4877-AC84-14546C4AADEBQ26771856-6C3AAEB1-D510-483F-94F1-0F7E6F02CCC9Q28165446-83ED9F16-FB11-4083-80AE-944ED479A246Q28166112-4731F07A-71A3-4996-B973-A2BB85006085Q28168215-B5D09682-D3B9-47D7-9CFA-9D4DDBD6F97EQ28174122-D8CEEEE5-399D-4E5F-8ACF-0BF010F1B543Q28194589-932F4B9C-5448-4261-9954-10FCC02D0734Q28201262-413B3C70-473C-4040-8A16-9AD629FACE09Q28210185-39520E53-48CA-4417-81D8-BA2689906CB4Q28211293-ECD836A1-CB2E-4546-8455-DC199840C24BQ28217965-B47CD8C3-0592-4189-84D7-AF8B84DE3451Q30275780-F499874C-B8F5-407D-A0B3-41064DE78AD5Q30300955-12423799-6E81-45FE-89DE-8CD5B47B170CQ30410446-91CB1A11-2D5F-48B2-8E63-22E682D8C9DEQ33598927-C3C79C65-B303-4952-AF4C-B3065A0BE262Q33846722-813340E7-4201-4251-A7F9-42A4C792DDC3Q33949371-18C9D641-3D80-492F-836F-06DA8CB4124BQ34816040-31125C1D-5522-4C76-8042-444B9ACA39A3Q35228588-43ED9325-245B-445B-9304-91DEC0452CF9Q35502326-51983044-FFD8-4D0E-B0DC-3D79887E28A3Q35678040-AC0B5A89-3EB9-4F00-865B-15F89401C011Q36135384-34E98CC1-90BF-4A29-9FBD-5FF8AFFD6201Q36357862-B357EEA6-0B3D-4BB8-9948-0F0AC964ECD6Q36418914-3EB66FA5-C08D-478A-9811-A7A9C9C25AE0Q36612656-EEF0E016-A2FD-4736-ADEC-921DDCA88582Q36834723-EB1A34AE-6D73-4EF6-8528-8399FD89CB53Q37073991-7E79E3EB-7DD6-4BEC-BBE8-8B94339EC857Q37240446-B8E5C4C4-A9DF-49AC-8BCC-2FC573EB8E19Q37485583-B0B77221-C6E4-4DC8-BD39-860305AA3EBDQ38348606-50E4677F-0A7C-41AE-B18D-1968590836D2Q38412095-4291478E-9C7C-4D55-A2F4-AA04EC557ECBQ38455960-1D4A0579-6502-437C-976F-04E5FA6B30B6Q38633155-82180C54-20F2-47B2-9308-9C0E6C3586B3Q38780339-4E023F03-5413-4C21-BCDC-33679B9F2A49Q38806426-C602D565-B4B9-4DA2-A356-BB8BEB89B246Q38973971-06536022-E52E-4D02-8CA9-C5C4A213694FQ40733686-0AEB826C-25BB-446B-8564-D0C5C9A3FC70Q46588700-16A34303-3426-4953-BE0C-31C239D98E8AQ46858455-64423F66-D742-4D7E-9BD3-CFFE427F5FBF
P2860
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
@ast
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
@en
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
@nl
type
label
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
@ast
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
@en
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
@nl
prefLabel
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
@ast
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
@en
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
@nl
P2093
P2860
P921
P356
P1433
P1476
The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients
@en
P2093
P2860
P304
P356
10.1136/THORAX.57.7.569
P407
P577
2002-07-01T00:00:00Z